Cyclobenzaprine Hcl
Cyclobenzaprine Hcl

1.56
Resolves muscle spasms and alleviates localized stiffness for Pain Management by reducing tonic motor activity to facilitate the restoration of physical movement.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Cyclobenzaprine
Reference Brand
Cyclobenzaprine
Product Origin
Generic Product
Reference Manufacturer
Various local manufacturers
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Pain Management
Product Category
Muscle Relaxant
Pharmacological Class
Skeletal muscle relaxants
Clinical Indications
Muscle spasms
Manufacturer Description
Cyclobenzaprine hcl is indicated to relieve muscle spasms. It is intended to support the physical recovery of muscles by reducing involuntary contractions and strain.
Mechanism of Action
Cyclobenzaprine acts on the central nervous system, particularly the brainstem, to lower muscle activity and reduce the transmission of pain signals causing muscle spasms.
Route of Administration
Oral
Onset Time
1 hour
Duration
12–24 hours
Contraindications
Recent heart attack, Hyperthyroidism
Severe Adverse Events
Arrhythmia, Confusion
Common Side Effects
Drowsiness, Dry mouth
Uncommon Side Effects
Dizziness, Fatigue
Drug Interactions
MAO inhibitors, Alcohol
Pregnancy Safety Warnings
Use only if clearly needed.
Age Restrictions
Not for use in children.
Storage Guidelines
Store at room temperature.
Related Products
Baclofen, Tizanidine

Cyclobenzaprine Hcl FAQ

How can patients in Singapore verify the regulatory compliance and sourcing standards of digital health directories providing Cyclobenzaprine Hcl?

Verification requires checking if the directory adheres to Health Sciences Authority (HSA) guidelines and utilizes local, verified hubs for the distribution of medical supplies.

Why do cost variations exist between multi-source generic Cyclobenzaprine formulations and originator brands?

Formulation economics, including different manufacturing processes or binder ingredients, contribute to cost differences, even when the active ingredient remains chemically bioequivalent.

How do digital health platforms facilitate evaluation and access to Cyclobenzaprine Hcl in Singapore?

Digital platforms provide a mechanism for remote consultations with practitioners, who then determine if the medication supports the patient’s specific needs before facilitating access through verified channels.

What are the logistical considerations when utilizing cross-border facilitation or importing medications into Singapore?

Importing medicinal compounds often triggers strict regulatory oversight, and individuals must ensure any incoming substance aligns with HSA import requirements for personal use to maintain legal compliance.

How does the clinical bioequivalence of generic Cyclobenzaprine Hcl compare to originator formulas?

Generic Cyclobenzaprine Hcl is formulated to meet industry standards for bioequivalence, ensuring it provides a similar therapeutic profile and rate of absorption as the originally researched compound.

Understanding Cyclobenzaprine

Skeletal muscle relaxation occurs through the modulation of neuronal activity within the central nervous system. Cyclobenzaprine functions as a centrally acting muscle relaxant used to manage acute musculoskeletal conditions. Healthcare providers integrate such compounds to support patient movement and functional recovery during periods of intense discomfort.

Chemical structures of this class interact with brainstem pathways to reduce tonic somatic motor activity. Patients requiring support for involuntary spasms find such interventions useful in temporary clinical protocols. Professionals recommend short-term use to facilitate physical therapy and rest.

Regulatory & Classification Profile

Cyclobenzaprine falls under the category of a Prescription-Only Medicine (POM) in Singapore. Regulatory frameworks governed by the Health Sciences Authority (HSA) designate such substances for professional assessment and clinical oversight. Access remains restricted to ensure that individuals receive appropriate guidance regarding the suitability of the compound within local health standards.

Formulations & Associated Medications

Cyclobenzaprine Hcl represents a bioequivalent generic formulation containing the active ingredient Cyclobenzaprine. Available formulations accessible through digital health directories include Cyclobenzaprine Hcl pill in strengths of 15mg. Such products provide the intended physiological response consistent with established chemical benchmarks for muscle relaxation and symptomatic support.

Therapeutic Applications

  • Muscle strain recovery among active adults.
  • Spasm reduction following acute mechanical injury.
  • Improvement of range of motion in patients experiencing painful musculoskeletal contractions.
  • Facilitation of physical therapy outcomes in sedentary or injured populations.

Biological Action

Nerve signals responsible for muscle tension undergo dampening within the central nervous system when this compound reaches systemic circulation. Signals travel through the spinal cord and brainstem, where the chemical prevents the over-activity that causes rigid, painful contractions. Muscles relax as a result of redirected neural impulse conduction. Gradual onset of action provides relief for the targeted musculoskeletal areas.

Treatment Landscape & Drug Class

Cyclobenzaprine belongs to the class of skeletal muscle relaxants. Modern protocols utilize these compounds as adjuncts to rest and purposeful physical exercise to address acute, temporary musculoskeletal pain. Medical practitioners categorize these agents based on their ability to dampen motor output without causing paralysis or generalized sedation compared to deeper anesthetic agents.

Understanding the Safety Profile

Cyclobenzaprine affects systemic physiological systems, particularly hepatic metabolic pathways and the central nervous system. Proper monitoring ensures that the compound facilitates therapeutic goals while minimizing unwanted strain on bodily organs. Clinical assessment remains necessary to monitor how individual patients process the chemical components over the duration of a treatment period. Refer to the clinical data tables provided for specific contraindications, interactions, and potential reactions.

Clinical Disclosure

This text provides an educational overview of Cyclobenzaprine and its biological function. Medicines like Cyclobenzaprine Hcl differ in strength based on formulation and regulatory requirements. Content presented here does not constitute medical advice, and liability for individual health outcomes remains with independent clinical decisions. Always consult official labeling and a qualified healthcare professional in Singapore before beginning any course of treatment or accessing specialized medicinal formulations.

Clinical Glossary

Muscle Relaxant
A pharmacological agent that acts on the nervous system to decrease muscle tone and alleviate spasms.
Bioequivalence
The standard demonstrating that a generic product delivers the same amount of active ingredient to the bloodstream as the originator formula.
Skeletal Muscle
Voluntary muscle tissue that moves the bones and supports the structural posture of the body.
Spasm
An involuntary, painful contraction of a muscle or muscle group often resulting from injury or strain.
Information associated with Cyclobenzaprine Hcl is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
Categories